Exicure, Inc. (XCUR)
NASDAQ: XCUR · IEX Real-Time Price · USD
+0.002 (0.67%)
At close: Jul 12, 2024, 4:00 PM
-0.001 (-0.39%)
After-hours: Jul 12, 2024, 6:35 PM EDT

Company Description

Exicure, Inc. does not have significant operations.

previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets.

Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Exicure, Inc.
Exicure logo
Country United States
Founded 2011
Industry Biotechnology
Sector Healthcare
Employees 5
CEO Paul Kang

Contact Details

2430 N. Halsted St.
Chicago, Illinois 60614
United States
Phone 847-673-1700
Website exicuretx.com

Stock Details

Ticker Symbol XCUR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001698530
CUSIP Number 30205M101
ISIN Number US30205M2008
Employer ID 81-5333008
SIC Code 2834

Key Executives

Name Position
Paul Kang Chief Executive Officer and Director
Jiyoung Hwang Chief Financial Officer and Director
Joshua Miller Chief Accounting Officer
Bart Anderson Senior Director of Research & Development

Latest SEC Filings

Date Type Title
Jul 2, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jul 1, 2024 8-K Current Report
Jun 25, 2024 8-K Current Report
Jun 17, 2024 10-Q Quarterly Report
Jun 17, 2024 8-K Current Report
Jun 11, 2024 ARS Filing
Jun 11, 2024 DEF 14A Other definitive proxy statements
Jun 6, 2024 10-K Annual Report
Jun 6, 2024 8-K Current Report
Jun 6, 2024 10-Q/A [Amend] Quarterly report